LIVE

ZLAB

Zai Lab Limited

ZLAB

NASDAQ·Healthcare·Biotechnology·Mkt cap $2.2B

$19.12

-0.16%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$15.96 - $41.20

P/E

-38.24

Fwd P/E

-11.31

Beta

0.78

Div Yield

0.00%

Avg Vol

887.8K

Shares Out

Mkt Cap

$2.2B

Price action

Price chart

Down 46.0% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

No bull reasons captured for this rating yet.

Bear Case

1 risk

  • Low volatility (beta 0.8).

Growth

Strong growth ahead

Value

Deep value opportunity - significant discount to sector peers

Momentum

Weak

-6.2% over 3m

Quality

Strong

Below average quality

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Aug 6, 2026

LATEST RECAP

Earnings recap unavailable for this period.

EPS surprise · last 4Q

Q1 26

-$0.50

Next: Aug 6, 2026

Revenue trend · last 1Q

Q1 26

$99.6M

Margins · last 1Q

Profit

-51.2%

Wall Street consensus

2 analysts · 100% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

2

100%

Hold

0%

Sell

0%

Median Price Target

Latest: Citi · May 8, 2026

vs Industry

How ZLAB stacks vs Biotechnology

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.

Related

Peers & themes

Peers

No peer data available.

Themes

No themes assigned.